Bio stimulator
News
23.09.2023
Focus on hyperpigmentation:
Treatment options and combination therapy in everyday practice Hyperpigmentation plays a major role in the daily routine of dermatologists. Solar radiation, stress and various noxae are regarded as triggers for […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
24.04.2017
Hologic Completes Acquisition of Cynosure
„We are pleased to complete our acquisition of Cynosure, and look forward to working with Michael Davin and the entire Cynosure team to achieve even greater success in the large, rapidly growing medical […]